Skip to main content
Equibles
GALT logo

GALT · Galectin Therapeutics Inc

Track GALT — free

Use GALT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.61 +0.26 (+5.98%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”
View the 10-Q filed Aug 14, 2026
Market Cap
$464.92M
Shares
100.85M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-03-10 Virtual KOL Event Event
2025-10-21 H.C. Wainwright Liver Disease Virtual Conference Conference
2025-09-08 H.C. Wainwright 27th Annual Global Investment Conference Conference
2025-06-16 Virtual KOL Event Event
2025-01-23 Annual Meeting of Stockholders Shareholder meeting
2024-10-07 H.C. Wainwright MASH Investment Conference Conference
2024-09-09 H.C. Wainwright 26th Annual Global Investment Conference Conference
2024-05-20 H.C. Wainwright BioConnect Investor Conference Conference
2023-10-24 H.C. Wainwright 7th Annual NASH Investor Conference Conference
2023-05-02 H.C. Wainwright BioConnect Investment Conference Conference
2022-01-10 H.C. Wainwright BIOCONNECT Virtual Conference Conference
2021-12-03 Annual Meeting of Stockholders Shareholder meeting
2021-04-29 4th Global NASH Congress Event
2021-03-09 H.C. Wainwright Global Life Sciences Conference Conference
2020-12-17 4th Annual Digital NASH Summit Event
2020-09-29 Galectin Therapeutics Investor Update Call Event
2020-09-14 H.C. Wainwright 22nd Annual Global Investment Conference Conference
2020-02-11 3rd Global NASH Congress 2020 Event
2019-12-04 Corporate Update Event
2019-04-09 2019 H.C. Wainwright Global Life Sciences Conference Conference
2018-09-06 H.C. Wainwright 20th Annual Global Investment Conference Conference
2018-04-14 The International Liver CongressTM 2018, European Association for the Study of the Liver (EASL) Event
2018-04-09 H.C. Wainwright Global Life Sciences Conference Conference
2018-03-19 2nd Annual H.C. Wainwright NASH Investor Conference. New York, NY Conference
2018-03-19 Bio Asia, Tokyo, Japan Event

Source: https://investor.galectintherapeutics.com/news-releases/news-release-details/galectin-therapeutics-phase-2-nash-cirrhosis-clinical-trial

Key facts CIK 1133416 CUSIP 363225202 13F (30d) 67 filings 65 filers Visit website Investor relations